STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress
- 29 January 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (7), 2902-2907
- https://doi.org/10.1073/pnas.0909086107
Abstract
We provide unprecedented genetic and biochemical evidence that the antiapoptotic transcription factor STAT3 serves as a substrate for SYK tyrosine kinase both in vitro and in vivo. Induction of SYK in an ecdysone-inducible mammalian expression system results in STAT3 activation, as documented by tyrosine phosphorylation and nuclear translocation of STAT3, as well as amplified expression of several STAT3 target genes. STAT3 activation after oxidative stress (OS) is strongly diminished in DT40 chicken B-lineage lymphoma cells rendered SYK-deficient by targeted disruption of the syk gene. Introduction of a wild-type, C-terminal or N-terminal SH2 domain-mutated, but not a kinase domain-mutated, syk gene into SYK-deficient DT40 cells restores OS-induced enhancement of STAT-3 activity. Thus, SYK plays an important and indispensable role in OS-induced STAT3 activation and its catalytic SH1 domain is critical for this previously unknown regulatory function. These results provide evidence for the existence of a novel mode of cytokine-independent cross-talk that operates between SYK and STAT3 pathways and regulates apoptosis during OS. We further provide experimental evidence that SYK is capable of associating with and phosphorylating STAT3 in human B-lineage leukemia/lymphoma cells challenged with OS. In agreement with a prerequisite role of SYK in OS-induced STAT3 activation, OS does not induce tyrosine phosphorylation of STAT3 in SYK-deficient human proB leukemia cells. Notably, inhibition of SYK with a small molecule drug candidate prevents OS-induced activation of STAT3 and overcomes the resistance of human B-lineage leukemia/lymphoma cells to OS-induced apoptosis.Keywords
This publication has 63 references indexed in Scilit:
- Novel STAT3 Target Genes Exert Distinct Roles in the Inhibition of Mesoderm and Endoderm Differentiation in Cooperation with NanogThe International Journal of Cell Cloning, 2009
- Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic targetBlood, 2009
- BLNK suppresses pre–B-cell leukemogenesis through inhibition of JAK3Blood, 2009
- Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cellsLeukemia, 2008
- SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphomaPublished by American Society of Hematology ,2008
- Deregulated Syk inhibits differentiation and induces growth factor–independent proliferation of pre–B cellsThe Journal of Experimental Medicine, 2006
- Stat3 confers resistance against hypoxia/reoxygenation-induced oxidative injury in hepatocytes through upregulation of Mn-SODJournal of Hepatology, 2004
- H2O2-induced Intermolecular Disulfide Bond Formation between Receptor Protein-tyrosine PhosphatasesPublished by Elsevier BV ,2004
- Ecdysone-inducible gene expression in mammalian cells and transgenic mice.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Physical and Functional Interactions between Lyn and p34 Kinases in Irradiated Human B-cell PrecursorsPublished by Elsevier BV ,1996